期刊
JOURNAL OF CELLULAR PHYSIOLOGY
卷 237, 期 2, 页码 1245-1265出版社
WILEY
DOI: 10.1002/jcp.30627
关键词
GSDMD; inflammation; NLRP3; obesity; pyroptosis
资金
- Natural Science Foundation of China [81860762]
- Scientific Research Guiding Plan Topic of Qinghai Hygiene Department [2018-wjzdx-131]
- Major National Scientific Research Projects [2015CB943102]
- Qinghai fundamental Scientific and Technological Research Plan [2018-ZJ-721]
- Key research and development projects Shaanxi Province [2021NY-020]
Obesity is characterized by persistent low-level inflammation and insulin resistance, with pyroptosis playing a significant role in the pathogenesis of chronic inflammatory diseases. Targeting pyroptosis-related molecules may offer a new potential therapy for obesity-related inflammatory diseases.
The main manifestation of obesity is persistent low-level inflammation and insulin resistance, which is an important factor inducing or promoting other obesity-related diseases. As a proinflammatory programmed cell death, pyroptosis plays an important role, especially in the activation and regulation of the NLRP3 inflammasome pathway. Pyroptosis is associated with the pathogenesis of many chronic inflammatory diseases and is characterized by the formation of micropores in the plasma membrane and the release of a large number of proinflammatory cytokines. This article mainly introduces the main pathways and key molecules of pyroptosis and focuses on the phenomenon of pyroptosis in obesity. It is suggested that the regulation of pyroptosis-related targets may become a new potential therapy for the prevention and treatment of systemic inflammatory response caused by obesity, and we summarize the potential molecular substances that may be beneficial to obesity-related inflammatory diseases through target pyroptosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据